Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

被引：0
作者：
M. J. Steinhardt
E. Wiercinska
M. Pham
G. U. Grigoleit
A. Mazzoni
M. Da-Via
X. Zhou
K. Meckel
K. Nickel
J. Duell
F. C. Krummenast
S. Kraus
C. Hopkinson
B. Weissbrich
W. Müllges
G. Stoll
K. M. Kortüm
H. Einsele
H. Bonig
L. Rasche
机构：
[1] University Hospital Würzburg,Department of Internal Medicine II
[2] Department of Cellular Therapeutics (GMP),Institute of Diagnostic and Interventional Neuroradiology
[3] German Red Cross Blood Service BaWüHe,Immunohematology Unit
[4] Institute Frankfurt,Institute of Virology and Immunobiology
[5] University Hospital of Würzburg,Department of Neurology
[6] Azienda Ospedaliera Universitaria Pisana,Institute for Transfusion Medicine and Immunohematology
[7] Northeastern Oklahoma Community Health Center,Mildred Scheel Early Career Center
[8] University of Würzburg,undefined
[9] University Hospital Würzburg,undefined
[10] Goethe University,undefined
[11] University Hospital of Würzburg,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
Myeloma; JCV; Prodigy; CCS; PML; Donor lymphocytes; Adaptive cell transfer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 80 条
  • [1] Schulz M(2014)Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems Transfusion 54 1622-1629
  • [2] Bialleck H(2015)Progressive Multifocal Leukeoncephalopathy C. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives Ther Adv Neurol Disord 8 255-273
  • [3] Thorausch K(2014)Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation-can preemptive detection of John Cunningham virus be useful? Int J Infect Dis 26 107-109
  • [4] Bug G(2018)Allogeneic BK virus-specific T cells for progressive multifocal leukoencephalopathy N Engl J Med 379 1443-1451
  • [5] Dunzinger U(2011)Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient Bone Marrow Transplant 46 987-992
  • [6] Seifried E(2019)Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma PLoS One 14 e0211927-528
  • [7] Pavlovic D(2018)Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma N Engl J Med 378 518-189
  • [8] Patera AC(2019)Infectious and immunological sequelae of daratumumab in multiple myeloma Br J Haematol 185 187-1438
  • [9] Nyberg F(2013)PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section Neurology 80 1430-711
  • [10] Gerber M(2007)Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera J Infect Dis 196 709-343
12345678